- Home
- HOLO vs ICCM Comparison
HOLO vs ICCM Comparison
Compare HOLO & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HOLO | ICCM |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.8M | 43.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HOLO | ICCM |
|---|---|---|
| Price | $2.18 | $0.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | ★ 583.7K | 204.3K |
| Earning Date | 08-10-2023 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 13.81 | N/A |
| Revenue | ★ $44,840,587.00 | $2,975,000.00 |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | N/A | $31.38 |
| P/E Ratio | $0.16 | ★ N/A |
| Revenue Growth | ★ 37.10 | N/A |
| 52 Week Low | $2.02 | $0.54 |
| 52 Week High | $72.40 | $1.66 |
Technical Indicators
Market Signals| Indicator | HOLO | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 35.38 | 36.76 |
| Support Level | $2.02 | $0.59 |
| Resistance Level | $2.30 | $0.62 |
| Average True Range (ATR) | 0.17 | 0.03 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 18.18 | 25.73 |
Price Performance
Historical ComparisonAbout HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.